A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development ...

The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...

It costs money to maintain the various facilities, utilities and personnel that allow scientists to conduct research in the ...

We came across a bullish thesis on Mettler-Toledo International Inc. (MTD) on Substack by Douglas Ott. In this article, we will summarize the bulls’ thesis on MTD. Mettler-Toledo International Inc.

The three-day-long 16th Asia Pharma Expo'-2025 kicked off at the Bangladesh-China Friendship Exhibition Center in Purbachal New Town today (12 February). The Bangladesh Association of Pharmaceutical ...

Notably, indirect costs from grants do not cover the full cost of carrying out research at universities. In 2023, colleges and universities contributed approximately $27 billion of their own funding, ...

The National Institutes of Health would slash funding for medical research doesn't make even cynical political sense. It's a ...

And what the heck is bio-convergence, anyway? It's where biology, engineering and artificial intelligence converge.

The famed cherry blossoms on the University of Washington campus in Seattle. (GeekWire File Photo / Kurt Schlosser) The fight ...

If all this sounds familiar, you’re probably thinking of Theranos, but SiPhox says their product really works and could be in ...